Tiel-van Buul M M, Mulder C J, van Royen E A, Wiltink E H, Tytgat G N
Department of Nuclear Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
Clin Pharmacokinet. 1991 Mar;20(3):247-51. doi: 10.2165/00003088-199120030-00006.
In order to investigate the retrograde spread in the colon and its relationship to the extent of the diseased area, the authors evaluated a 100ml enema of mesalazine (5-aminosalicylic acid, Pentasa') lg in a consecutive series of 30 patients with ulcerative colitis. The enema was labelled with 10 MBq 99mtechnetium-human serum albumin microcolloid. Sequential scintigraphic imaging was performed in all patients, and the results compared with the extension of the disease as found by colonoscopy. If the enema reached the entire affected area it was interpreted as 'topically adequate'. In 80% of the patients there was retrograde spread of the enema beyond the rectosigmoid, thus reaching the affected area in ulcerative colitis. No relationship was found between the extent of dispersion of the enema and the time of defecation prior to scintigraphy. The authors conclude that a 100ml 'Pentasa' enema may be adequate for treatment of ulcerative colitis extending up to the splenic flexure.
为了研究灌肠剂在结肠中的逆行扩散及其与病变区域范围的关系,作者对连续30例溃疡性结肠炎患者使用100ml美沙拉嗪(5-氨基水杨酸,颇得斯安)灌肠剂(含1g药物)进行评估。该灌肠剂用10MBq的99m锝-人血清白蛋白微胶体标记。对所有患者进行了连续的闪烁显像,并将结果与结肠镜检查发现的疾病范围进行比较。如果灌肠剂到达整个受累区域,则认为“局部足够”。80%的患者灌肠剂逆行扩散至直肠乙状结肠以外,从而到达溃疡性结肠炎的受累区域。在闪烁显像前灌肠剂的扩散范围与排便时间之间未发现相关性。作者得出结论,100ml的“颇得斯安”灌肠剂可能足以治疗延伸至脾曲的溃疡性结肠炎。